Hemera Biosciences Company
Hemera Biosciences developed HMR59 is a one-time gene therapy developed to treat both dry and wet macular degeneration.
Technology:
Regenerative Medicine
Industry:
Biotechnology, Gene therapy, Genetics
Headquarters:
Newton, Massachusetts, United States
Founded Date:
2010
Employees Number:
1-10
Funding Status:
Venture Round
Investors Number:
2
Total Funding:
1.3M
Last Funding Date:
Apr 1, 2013
Last Funding Type:
Venture Round
Register and Claim Ownership